No takes yet. Share an insight, caveat, or question.
Review analyzes advancements in lung cancer diagnosis using molecular biomarkers and AI technologies, indicating significant potential for improved outcomes.
Saha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: